| NCT Number | NCT07275151 |
| Lead Sponsor | CathVision ApS |
| Conditions | Atrial Fibrillation |
| Enrollment | 40 participants |
| Start Date | 2026-07-22 |
| Primary Completion | 2026-10-31 (estimated) |
| Study Completion | 2026-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-23 |